Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Liu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|August 13, 2015
Targeted Therapy in Biliary Tract CancersAmartej Merla, Kenneth G Liu, Lakshmi Rajdev
Oncotarget|January 7, 2017
Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospectsKenneth G Liu, Sorab Gupta, Sanjay Goel
Biomarker Research|October 26, 2016
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?Kenneth G Liu, Amit Verma, Olga Derman, et al.
Laboratory Medicine|July 30, 2024
Prothrombin deficiency with recurrent subretinal hemorrhageEros Qama, Kritika Krishnamurthy, Joseph J Mulvey, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|August 13, 2015
Targeted Therapy in Biliary Tract CancersAmartej Merla, Kenneth G Liu, Lakshmi Rajdev
Oncotarget|January 7, 2017
Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospectsKenneth G Liu, Sorab Gupta, Sanjay Goel
Biomarker Research|October 26, 2016
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?Kenneth G Liu, Amit Verma, Olga Derman, et al.
Laboratory Medicine|July 30, 2024
Prothrombin deficiency with recurrent subretinal hemorrhageEros Qama, Kritika Krishnamurthy, Joseph J Mulvey, et al.
Pageof 1